Crunching the numbers for EW... Refresh in a moment for the full analysis.
Edwards Lifesciences Corp (EW)
Healthcare
healthy
$79.64
Updated: 2026-04-09
Financial Strength
75
Strong
Capital Allocation
55
Mixed
Key Findings
+
Net cash position — more cash on hand than total debt
−
Sharp revenue decline — sales down more than 15% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.